» Articles » PMID: 14525774

T-cell Homeostasis in Humans with Thymic Hypoplasia Due to Chromosome 22q11.2 Deletion Syndrome

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2003 Oct 4
PMID 14525774
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) typically exhibit thymic hypoplasia, conotruncal cardiac defects, and hypoparathyroidism. The immunodeficiency that results from the thymic hypoplasia has been extensively described and consists primarily of T-cell lymphopenia. A curious feature of the T-cell lymphopenia is that the age-related rate of decline of T-cell numbers is slower in patients than controls. This leads to T-cell numbers in adulthood that are minimally decreased compared with controls. This suggests that homeostatic mechanisms might be acting to preserve the peripheral blood T-cell numbers in patients. We characterized changes in CD4/CD45RA and CD4/CD45RO T-cell populations in patients and controls of various ages and determined T-cell recombination excision circles and telomere length within the CD4/CD45RA population. Patients had evidence of accelerated conversion of naive to memory cells and had evidence of more extensive replicative history within the CD4/CD45RA compartment compared with controls. Oligoclonal T-cell receptor (TCR) Vbeta families and missing Vbeta families were seen more often in patients than controls. These data are consistent with homeostatic proliferation of T cells in patients with limited T-cell production due to thymic hypoplasia.

Citing Articles

Review of the Pathophysiology and Clinical Manifestations of 22q11.2 Deletion and Duplication Syndromes.

Purow J, Waidner L, Ale H Clin Rev Allergy Immunol. 2025; 68(1):23.

PMID: 40038168 DOI: 10.1007/s12016-025-09035-4.


Systemic lupus erythematosus in a patient with 22q11.2 deletion syndrome: A case report and review of the literature.

Sun C, Han P, Yan J Cent Eur J Immunol. 2024; 49(3):315-319.

PMID: 39720268 PMC: 11664810. DOI: 10.5114/ceji.2024.143229.


Case report: Artificial thymic organoids facilitate clinical decisions for a patient with a variant and severe persistent T cell lymphopenia.

Gall A, Bosticardo M, Ma S, Chen K, Amini K, Pala F Front Immunol. 2024; 15:1438383.

PMID: 39364398 PMC: 11448704. DOI: 10.3389/fimmu.2024.1438383.


Understanding the Variability of 22q11.2 Deletion Syndrome: The Role of Epigenetic Factors.

Cillo F, Coppola E, Habetswallner F, Cecere F, Pignata L, Toriello E Genes (Basel). 2024; 15(3).

PMID: 38540380 PMC: 10969806. DOI: 10.3390/genes15030321.


Primary and secondary defects of the thymus.

Dinges S, Amini K, Notarangelo L, Delmonte O Immunol Rev. 2024; 322(1):178-211.

PMID: 38228406 PMC: 10950553. DOI: 10.1111/imr.13306.